PLEASANTON, California, August 26, 2026, 17:41 EDT — Veeva Systems (VEEV.N) advanced 8.2%, adding $3.3 billion in market capitalization, after the company raised its sales outlook on the back of increasing demand for its artificial intelligence products.
- Veeva shares rose 8.24% after hours to $265.09, compared with their closing price of $244.91.
- Revenue for the fiscal second quarter increased 18% to $928.0 million.
- Revenue from R&D and Quality subscriptions rose 19% to reach $419.4 million.
- Veeva increased its full-year revenue midpoint by $44.5 million.
Veeva Systems Inc. (NYSE:VEEV) shares surged as the life-sciences software firm surpassed quarterly forecasts and lifted its full-year guidance. The stock climbed to $265.09 at 17:40 EDT, up 8.24% in after-hours trading latest quote.
The action represented an approximate $3.28 billion increase in equity value. This is double Veeva’s projected yearly operating cash flow and nearly 74 times higher than the rise in revenue guidance.
Revenue for the fiscal second quarter rose 18% to $928.0 million, surpassing the analyst forecast of $905.4 million by 2.5%. Adjusted earnings came in at $2.35 per share, exceeding the consensus estimate of $2.22 estimate comparison.
| Metric | Q2 FY2027 | Q2 FY2026 | Change |
|---|---|---|---|
| Total revenue | $928.0 million | $789.1 million | +18% |
| Subscription revenue | $766.8 million | $659.2 million | +16% |
| GAAP operating income | $275.0 million | $195.9 million | +40% |
| Adjusted operating income | $415.9 million | $352.6 million | +18% |
| Normalized billings | $768 million | $666 million | +15% |
Subscriptions related to R&D and Quality accounted for the largest share, with revenue climbing 19% to $419.4 million. Revenue from commercial subscriptions grew 13%, reaching $347.4 million earnings presentation.
Chief Executive Peter Gassner reported that Vault CRM achieved its strongest quarter to date. Over 180 customers are currently using the system. Twelve out of the top 20 biopharma firms have made global commitments company release.
Veeva disclosed that five initial customers have adopted its Falcon agent platform. Veeva Safety surpassed 100 customers. More than 30 customers were added to Veeva’s Quality products in the quarter.
The company now expects full-year revenue between $3.682 billion and $3.687 billion, up from the earlier forecast of $3.635 billion to $3.645 billion. Adjusted operating income guidance climbed by $30 million to roughly $1.64 billion previous outlook.
Veeva raised its adjusted earnings outlook to $9.21 per share, up from $9.05. The company forecasts adjusted operating cash flow of about $1.6 billion, suggesting a margin close to 43%.
The forecast for the third quarter indicates a slight slowdown. Projected revenue of $932 million to $935 million suggests growth of roughly 15%. Subscription revenue is anticipated to be close to $782 million.
GAAP operating income increased by 40%, doubling the pace of revenue expansion. Adjusted operating margin remained steady at 44.8%. GAAP operating cash flow for the quarter was little changed at $238.7 million.
Veeva allocated $472.7 million to buybacks in the first half. Its after-hours value increase was almost seven times larger than that amount. The company reported $7.24 billion in cash and short-term investments.
Of 30 ratings, Wall Street gives an average recommendation of Overweight. After-hours, the price at $265.09 was 5.6% higher than the $251.04 average target, but 0.3% under the $266 median analyst estimates.
The shares changed hands at 28.8 times Veeva’s updated adjusted earnings outlook. That valuation expects sustained subscription expansion. It offers little cushion if customer migrations slow down.
Risks persist. Third-quarter growth is forecast to be slower than in the previous quarter. Vault CRM has secured 12 commitments from the top 20, with decisions still pending from eight customers. Delays in deployments may occur due to competition, product-security issues, or reduced funding in the drug industry.
Investors are set to gauge the rally as third-quarter revenue falls within the $932 million to $935 million range. Maintaining R&D and Quality expansion close to 19% would help underpin the increased annual outlook.


